Annual summary of publications

Publications (original articles or review articles) published in 2009 from OUS - Department of Endocrinology, Morbid Obesity and Preventive Medicine

117 publications found

Aas AM, Ohrvik J, Malmberg K, Rydén L, Birkeland KI, DIGAMI 2 Investigators (2009)
Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study
Diabetes Obes Metab, 11 (4), 323-9
DOI 10.1111/j.1463-1326.2008.00964.x, PubMed 19267710

Aasen G, Fagertun H, Tonstad S, Halse J (2009)
Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men
Scand J Clin Lab Invest, 69 (2), 181-9
DOI 10.1080/00365510802464641, PubMed 18937100

Aasheim ET, Björkman S, Søvik TT, Engström M, Hanvold SE, Mala T, Olbers T, Bøhmer T (2009)
Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch
Am J Clin Nutr, 90 (1), 15-22
DOI 10.3945/ajcn.2009.27583, PubMed 19439456

Aasheim ET, Frigstad SO, Søvik TT, Birkeland KI, Haukeland JW (2009)
Hyperinsulinemic hypoglycemia and liver cirrhosis presenting after duodenal switch: a case report
Surg Obes Relat Dis, 6 (4), 441-3
DOI 10.1016/j.soard.2009.11.007, PubMed 20096646

Abedini S, Holme I, Fellström B, Jardine A, Cole E, Maes B, Holdaas H, ALERT Study Group (2009)
Cerebrovascular events in renal transplant recipients
Transplantation, 87 (1), 112-7
DOI 10.1097/TP.0b013e31818bfce8, PubMed 19136900

Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A, Cole E, Maes B, Neumayer HH, Grønhagen-Riska C, Ambühl P, Holdaas H, ALERT study group (2009)
Inflammation in renal transplantation
Clin J Am Soc Nephrol, 4 (7), 1246-54
DOI 10.2215/CJN.00930209, PubMed 19541816

Aksnes TA, Kjeldsen SE, Schmieder RE (2009)
Hypertension and atrial fi brillation with emphasis on prevention
Blood Press, 18 (3), 94-8
DOI 10.1080/08037050903040744, PubMed 20499443

Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D (2009)
Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study
Hypertension, 55 (2), 333-8
DOI 10.1161/HYPERTENSIONAHA.109.143982, PubMed 20038753

Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J (2009)
Time for new indications for statins?
Med Sci Monit, 15 (12), MS1-5
PubMed 19946240

Bangstad HJ, Seljeflot I, Berg TJ, Hanssen KF (2009)
Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes
Scand J Clin Lab Invest, 69 (1), 138-44
DOI 10.1080/00365510802444080, PubMed 18846477

Birkenaes AB, Birkeland KI, Friis S, Opjordsmoen S, Andreassen OA (2009)
Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions
J Clin Psychopharmacol, 29 (2), 109-16
DOI 10.1097/JCP.0b013e31819b95fc, PubMed 19512971

Bollerslev J, Fougner SL, Berg JP (2009)
New directions in pharmacological treatment of acromegaly
Expert Opin Investig Drugs, 18 (1), 13-22
DOI 10.1517/13543780802554357, PubMed 19053878

Bollerslev J, Rosen T, Mollerup CL, Nordenström J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S, SIPH Study Group (2009)
Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism
J Clin Endocrinol Metab, 94 (7), 2255-61
DOI 10.1210/jc.2008-2742, PubMed 19351725

Borota OC, Scheithauer BW, Fougner SL, Hald JK, Ramm-Pettersen J, Bollerslev J (2009)
Spindle cell oncocytoma of the adenohypophysis: report of a case with marked cellular atypia and recurrence despite adjuvant treatment
Clin Neuropathol, 28 (2), 91-5
DOI 10.5414/npp28091, PubMed 19353839

Brun H, Holmstrøm H, Thaulow E, Damås JK, Yndestad A, Aukrust P, Ueland T (2009)
Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation
Congenit Heart Dis, 4 (3), 153-9
DOI 10.1111/j.1747-0803.2009.00297.x, PubMed 19489942

Carvalho CM, Oliveira JE, Almeida BE, Ueda EK, Torjesen PA, Bartolini P, Ribela MT (2009)
Efficient isolation of the subunits of recombinant and pituitary glycoprotein hormones
J Chromatogr A, 1216 (9), 1431-8
DOI 10.1016/j.chroma.2008.12.096, PubMed 19167716

Dahl CP, Husberg C, Gullestad L, Waehre A, Damås JK, Vinge LE, Finsen AV, Ueland T, Florholmen G, Aakhus S, Halvorsen B, Aukrust P, Oie E, Yndestad A, Christensen G (2009)
Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling
Circ Heart Fail, 2 (6), 624-32
DOI 10.1161/CIRCHEARTFAILURE.108.821074, PubMed 19919988

de Simone G, Okin PM, Gerdts E, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Kjeldsen SE, Devereux RB (2009)
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study
Nutr Metab Cardiovasc Dis, 19 (9), 634-40
DOI 10.1016/j.numecd.2008.12.012, PubMed 19361968

De Stefani E, Aune D, Boffetta P, Deneo-Pellegrini H, Ronco AL, Acosta G, Brennan P, Ferro G, Mendilaharsu M (2009)
Salted meat consumption and the risk of cancer: a multisite case-control study in Uruguay
Asian Pac J Cancer Prev, 10 (5), 853-7
PubMed 20104978

De Stefani E, Deneo-Pellegrini H, Boffetta P, Ronco AL, Aune D, Acosta G, Mendilaharsu M, Brennan P, Ferro G (2009)
Dietary patterns and risk of cancer: a factor analysis in Uruguay
Int J Cancer, 124 (6), 1391-7
DOI 10.1002/ijc.24035, PubMed 19058195

Delmas PD, Munoz F, Black DM, Cosman F, Boonen S, Watts NB, Kendler D, Eriksen EF, Mesenbrink PG, Eastell R, HORIZON-PFT Research Group (2009)
Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis
J Bone Miner Res, 24 (9), 1544-51
DOI 10.1359/jbmr.090310, PubMed 19338427

Dolgos S, Hartmann A, Bønsnes S, Isaksen GA, Godang K, Ueland T, Pfeffer P, Bollerslev J (2009)
Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation
Scand J Clin Lab Invest, 69 (2), 161-7
DOI 10.1080/00365510802449634, PubMed 18972258

Dolgos S, Hartmann A, Jenssen T, Isaksen GA, Pfeffer P, Bollerslev J (2009)
Determinants of short-term changes in body composition following renal transplantation
Scand J Urol Nephrol, 43 (1), 76-83
DOI 10.1080/00365590802273226, PubMed 18777442

Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM, HORIZON Pivotal Fracture Trial (2009)
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial
Osteoporos Int, 21 (7), 1277-85
DOI 10.1007/s00198-009-1077-9, PubMed 19802508

Eggum R, Ueland T, Mollnes TE, Videm V, Fiane AE, Aukrust P, Lindberg HL (2009)
Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery
Interact Cardiovasc Thorac Surg, 10 (1), 76-80
DOI 10.1510/icvts.2009.213876, PubMed 19822605

Einvik G, Ekeberg O, Klemsdal TO, Sandvik L, Hjerkinn EM (2009)
Physical distress is associated with cardiovascular events in a high risk population of elderly men
BMC Cardiovasc Disord, 9, 14
DOI 10.1186/1471-2261-9-14, PubMed 19331677

Einvik G, Ekeberg O, Lavik JG, Ellingsen I, Klemsdal TO, Hjerkinn EM (2009)
The influence of long-term awareness of hyperlipidemia and of 3 years of dietary counseling on depression, anxiety, and quality of life
J Psychosom Res, 68 (6), 567-72
DOI 10.1016/j.jpsychores.2009.11.004, PubMed 20488274

Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES (2009)
Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry
J Clin Endocrinol Metab, 94 (12), 4882-90
DOI 10.1210/jc.2009-1368, PubMed 19858318

Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC, Larsen ML, Lindahl C, Olsson AG, Tikkanen MJ, Waters DD, Pedersen TR, Steering Committees of IDEAL and TNT Trials (2009)
Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease
Am J Cardiol, 104 (4), 459-63
DOI 10.1016/j.amjcard.2009.04.008, PubMed 19660594

Fjalestad T, Falch JA, Stromsoe K (2009)
Proximal humeral fractures and relation to osteoporosis: a cohort study of 49 hospitalized patients with 50 fractures
Eur. J. Orthop. Surg. Traumatol., 19 (7), 461-466

Graesdal A (2009)
[Use of omega-3 fatty acids in the prevention of heart disease]
Tidsskr Nor Laegeforen, 129 (20), 2109-12
DOI 10.4045/tidsskr.08.0447, PubMed 19855449

Gudmundsdottir H, Taarnhøj NC, Strand AH, Kjeldsen SE, Høieggen A, Os I (2009)
Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men
J Hum Hypertens, 24 (8), 505-13
DOI 10.1038/jhh.2009.94, PubMed 20010619

Halvorsen B, Heggen E, Ueland T, Smith C, Sandberg WJ, Damås JK, Otterdal K, Tonstad S, Aukrust P (2009)
Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
Eur J Endocrinol, 162 (2), 267-73
DOI 10.1530/EJE-09-0706, PubMed 19926782

Hampson SE, Tonstad S, Irgens LM, Meltzer HM, Vollrath ME (2009)
Mothers' negative affectivity during pregnancy and food choices for their infants
Int J Obes (Lond), 34 (2), 327-31
DOI 10.1038/ijo.2009.230, PubMed 19918247

Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M (2009)
Long-term stability of cardiovascular and catecholamine responses to stress tests: an 18-year follow-up study
Hypertension, 55 (1), 131-6
DOI 10.1161/HYPERTENSIONAHA.109.143164, PubMed 19948985

Haukeland JW, Konopski Z, Eggesbø HB, von Volkmann HL, Raschpichler G, Bjøro K, Haaland T, Løberg EM, Birkeland K (2009)
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
Scand J Gastroenterol, 44 (7), 853-60
DOI 10.1080/00365520902845268, PubMed 19811343

Heggen E, Granlund L, Pedersen JI, Holme I, Ceglarek U, Thiery J, Kirkhus B, Tonstad S (2009)
Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations
Nutr Metab Cardiovasc Dis, 20 (4), 258-65
DOI 10.1016/j.numecd.2009.04.001, PubMed 19748247

Hjelmesaeth J, Hofsø D, Aasheim ET, Jenssen T, Moan J, Hager H, Røislien J, Bollerslev J (2009)
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study
Cardiovasc Diabetol, 8, 7
DOI 10.1186/1475-2840-8-7, PubMed 19187564

Hofsø D, Jenssen T, Bollerslev J, Røislien J, Hager H, Hjelmesaeth J (2009)
Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study
Diabetes Res Clin Pract, 86 (1), e9-11
DOI 10.1016/j.diabres.2009.06.016, PubMed 19608292

Hofsø D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, Aukrust P, Røislien J, Hjelmesaeth J (2009)
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
Eur J Endocrinol, 161 (3), 451-8
DOI 10.1530/EJE-09-0421, PubMed 19542241

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Eur J Heart Fail, 11 (11), 1036-42
DOI 10.1093/eurjhf/hfp129, PubMed 19801574

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
J Intern Med, 266 (6), 558-70
DOI 10.1111/j.1365-2796.2009.02133.x, PubMed 19563390

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ann Med, 41 (7), 522-32
DOI 10.1080/07853890903089453, PubMed 19657769

Holme I, Fayyad R, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Holdaas H, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial
J Intern Med, 267 (6), 567-75
DOI 10.1111/j.1365-2796.2009.02176.x, PubMed 20141566

Holme I, Fellstrom B, Jardine A, Holdaas H (2009)
Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients
Atherosclerosis, 208 (1), 234-9
DOI 10.1016/j.atherosclerosis.2009.06.020, PubMed 19596331

Holme I, Strandberg TE, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)
Atherosclerosis, 205 (2), 522-7
DOI 10.1016/j.atherosclerosis.2009.01.023, PubMed 19327776

Holme I, Szarek M, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study
Eur J Cardiovasc Prev Rehabil, 16 (3), 315-20
DOI 10.1097/HJR.0b013e32832130f5, PubMed 19322096

Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, Agartz I, Ueland T, Andreassen OA (2009)
Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
Bipolar Disord, 11 (7), 726-34
DOI 10.1111/j.1399-5618.2009.00757.x, PubMed 19839997

Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
J Diabetes, 1 (3), 182-7
DOI 10.1111/j.1753-0407.2009.00031.x, PubMed 20923537

Johansen OE, Vanberg PJ, Kilhovd BK, Jørgensen AP (2009)
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
Vasc Health Risk Manag, 5 (1), 121-8
PubMed 19436668

Jorde R, Sneve M, Torjesen P, Figenschau Y (2009)
No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year
J Intern Med, 267 (5), 462-72
DOI 10.1111/j.1365-2796.2009.02181.x, PubMed 20141565

Khoury J, Amundsen AL, Tonstad S, Henriksen T, Ose L, Retterstøl K, Iversen PO (2009)
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
Acta Obstet Gynecol Scand, 88 (2), 222-6
DOI 10.1080/00016340802503047, PubMed 18972234

Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Hanssen KF, Laakso M (2009)
Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women
Atherosclerosis, 205 (2), 590-4
DOI 10.1016/j.atherosclerosis.2008.12.041, PubMed 19185865

Kjeldsen SE, Devereux RB, Hille DA, Lyle PA, Dahlöf B, Julius S, Edelman JM, Snapinn SM, de Faire U, Fyhrquist F, Ibsen H, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
Blood Press, 18 (6), 348-61
DOI 10.3109/08037050903460590, PubMed 20001655

Kjensli A, Falch JA, Ryg M, Blenk T, Armbrecht G, Diep LM, Ellingsen I (2009)
High prevalence of vertebral deformities in COPD patients: relationship to disease severity
Eur Respir J, 33 (5), 1018-24
DOI 10.1183/09031936.00073908, PubMed 19129288

Klemsdal TO, Holme I, Nerland H, Pedersen TR, Tonstad S (2009)
Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome
Nutr Metab Cardiovasc Dis, 20 (3), 195-201
DOI 10.1016/j.numecd.2009.03.010, PubMed 19502017

Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven KB, Halvorsen B, Aukrust P, Tonstad S (2009)
Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome
Scand J Clin Lab Invest, 69 (8), 858-64
DOI 10.3109/00365510903348677, PubMed 19929281

Landrø L, Damås JK, Halvorsen B, Fevang B, Ueland T, Otterdal K, Heggelund L, Frøland SS, Aukrust P (2009)
CXCL16 in HIV infection - a link between inflammation and viral replication
Eur J Clin Invest, 39 (11), 1017-24
DOI 10.1111/j.1365-2362.2009.02207.x, PubMed 19674076

Lekva T, Bollerslev J, Kristo C, Olstad OK, Ueland T, Jemtland R (2009)
The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis
J Clin Endocrinol Metab, 95 (1), 246-55
DOI 10.1210/jc.2009-0595, PubMed 19875485

Lekva T, Bollerslev J, Kristo CL, Olstad OK, Ueland T, Jemtland R (2009)
The Glucocorticoid-Induced Leucine Zipper Gene (GILZ) Expression Decreases after Successful Treatment of Patients with Endogenous Cushing's Syndrome and May Play a Role in Glucocorticoid-Induced Osteoporosis
Endocr Rev, 30 (7), 932
DOI 10.1210/edrv.30.7.9985, PubMed 28199557

Liavaag AH, Tonstad S, Pripp AH, Tropé C, Dørum A (2009)
Prevalence and determinants of metabolic syndrome and elevated Framingham risk score in epithelial ovarian cancer survivors: a controlled observational study
Int J Gynecol Cancer, 19 (4), 634-40
DOI 10.1111/IGC.0b013e3181a13058, PubMed 19509562

Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES (2009)
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone
Eur J Endocrinol, 160 (6), 993-1002
DOI 10.1530/EJE-08-0880, PubMed 19282465

Madsen LH, Lund T, Grieg Z, Nygaard S, Holmvang L, Jurlander B, Grande P, Christensen G, Atar D (2009)
Cardiac troponin I degradation in serum of patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous septal ablation
Cardiology, 114 (3), 167-73
DOI 10.1159/000226596, PubMed 19571537

Malterud K, Tonstad S (2009)
Preventing obesity: challenges and pitfalls for health promotion
Patient Educ Couns, 76 (2), 254-9
DOI 10.1016/j.pec.2008.12.012, PubMed 19157764

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Blood Press, 18 (6), 308-47
DOI 10.3109/08037050903450468, PubMed 20001654

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
J Hypertens, 27 (11), 2121-58
DOI 10.1097/HJH.0b013e328333146d, PubMed 19838131

Meuwese MC, de Groot E, Duivenvoorden R, Trip MD, Ose L, Maritz FJ, Basart DC, Kastelein JJ, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA, CAPTIVATE Investigators (2009)
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial
JAMA, 301 (11), 1131-9
DOI 10.1001/jama.301.11.1131, PubMed 19293413

Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Mohanavelu S, Rouleau J, Fox K, Pedersen TR, Califf RM (2009)
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome
Clin J Am Soc Nephrol, 4 (11), 1811-7
DOI 10.2215/CJN.03510509, PubMed 19820133

Morin DP, Oikarinen L, Viitasalo M, Toivonen L, Nieminen MS, Kjeldsen SE, Dahlöf B, John M, Devereux RB, Okin PM (2009)
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study
Eur Heart J, 30 (23), 2908-14
DOI 10.1093/eurheartj/ehp321, PubMed 19687165

Nätt D, Lindqvist N, Stranneheim H, Lundeberg J, Torjesen PA, Jensen P (2009)
Inheritance of acquired behaviour adaptations and brain gene expression in chickens
PLoS One, 4 (7), e6405
DOI 10.1371/journal.pone.0006405, PubMed 19636381

Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group (2009)
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study
Arthritis Rheum, 60 (4), 1060-4
DOI 10.1002/art.24379, PubMed 19333947

Okin PM, Devereux RB, Kjeldsen SE, Edelman JM, Dahlöf B (2009)
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study
J Hypertens, 27 (11), 2271-7
DOI 10.1097/HJH.0b013e328330b66b, PubMed 19834342

Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators (2009)
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)
Circulation, 119 (14), 1883-91
DOI 10.1161/CIRCULATIONAHA.108.812313, PubMed 19332468

Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
J Hypertens, 27 (3), 567-74
DOI 10.1097/HJH.0b013e32831daf96, PubMed 19262226

Orn S, Breland UM, Mollnes TE, Manhenke C, Dickstein K, Aukrust P, Ueland T (2009)
The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction
Am J Cardiol, 104 (9), 1179-83
DOI 10.1016/j.amjcard.2009.06.028, PubMed 19840558

Ørn S, Manhenke C, Ueland T, Damås JK, Mollnes TE, Edvardsen T, Aukrust P, Dickstein K (2009)
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
Eur Heart J, 30 (10), 1180-6
DOI 10.1093/eurheartj/ehp070, PubMed 19299430

Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD (2009)
Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
Brain Behav Immun, 23 (6), 868-74
DOI 10.1016/j.bbi.2009.04.003, PubMed 19362138

Ose L, Budinski D, Hounslow N, Arneson V (2009)
Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia
Curr Med Res Opin, 25 (11), 2755-64
DOI 10.1185/03007990903290886, PubMed 19785568

Ose L, Budinski D, Hounslow N, Arneson V (2009)
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia
Atherosclerosis, 210 (1), 202-8
DOI 10.1016/j.atherosclerosis.2009.12.009, PubMed 20080236

Osmancevic A, Nilsen LT, Landin-Wilhelmsen K, Søyland E, Abusdal Torjesen P, Hagve TA, Nenseter MS, Krogstad AL (2009)
Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis
J Eur Acad Dermatol Venereol, 23 (10), 1133-40
DOI 10.1111/j.1468-3083.2009.03245.x, PubMed 19453805

Parhofer KG, Birkeland KI, DeFronzo R, Del Prato S, Bhaumik A, Ptaszynska A (2009)
Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)
Int J Clin Pract, 64 (2), 160-8
DOI 10.1111/j.1742-1241.2009.02246.x, PubMed 19929980

Pedersen TR (2009)
Lipid-lowering drugs and risk for cancer
Curr Atheroscler Rep, 11 (5), 350-7
DOI 10.1007/s11883-009-0053-3, PubMed 19664378

Qvigstad E, Voldner N, Bollerslev J, Henriksen T (2009)
[Diabetes in pregnancy--prevention over generations]
Tidsskr Nor Laegeforen, 129 (23), 2494-6
DOI 10.4045/tidsskr.09.0712, PubMed 19997141

Qvigstad E, Voldner N, Godang K, Henriksen T, Bollerslev J (2009)
Overweight is associated with impaired beta-cell function during pregnancy: a longitudinal study of 553 normal pregnancies
Eur J Endocrinol, 162 (1), 67-73
DOI 10.1530/EJE-09-0416, PubMed 19841044

Rasmussen T, Stene LC, Samuelsen SO, Cinek O, Wetlesen T, Torjesen PA, Rønningen KS (2009)
Maternal BMI before pregnancy, maternal weight gain during pregnancy, and risk of persistent positivity for multiple diabetes-associated autoantibodies in children with the high-risk HLA genotype: the MIDIA study
Diabetes Care, 32 (10), 1904-6
DOI 10.2337/dc09-0663, PubMed 19592628

Reppe S, Refvem H, Gautvik VT, Olstad OK, Høvring PI, Reinholt FP, Holden M, Frigessi A, Jemtland R, Gautvik KM (2009)
Eight genes are highly associated with BMD variation in postmenopausal Caucasian women
Bone, 46 (3), 604-12
DOI 10.1016/j.bone.2009.11.007, PubMed 19922823

Retterstøl K, Hennig CB, Iversen PO (2009)
Improved plasma lipids and body weight in overweight/obese patients with type III hyperlipoproteinemia after 4 weeks on a low glycemic diet
Clin Nutr, 28 (2), 213-5
DOI 10.1016/j.clnu.2009.01.018, PubMed 19232793

Rødland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Frøland SS (2009)
Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis
Infect Immun, 78 (3), 1269-75
DOI 10.1128/IAI.01091-09, PubMed 20008537

Rønning P, Andresen PA, Hald JK, Heimdal K, Scheie D, Schreiner T, Helseth E (2009)
Low frequency of VHL germline mutations in Norwegian patients presenting with isolated central nervous system hemangioblastomas--a population-based study
Acta Neurol Scand, 122 (2), 124-31
DOI 10.1111/j.1600-0404.2009.01274.x, PubMed 19814753

Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B, PROactive investigators (2009)
Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)
Diabet Med, 26 (10), 1033-9
DOI 10.1111/j.1464-5491.2009.02816.x, PubMed 19900236

Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B, PROactive investigators (2009)
Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18)
Diabet Med, 26 (12), 1242-9
DOI 10.1111/j.1464-5491.2009.02857.x, PubMed 20002476

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J, dal-OUTCOMES Committees and Investigators (2009)
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
Am Heart J, 158 (6), 896-901.e3
DOI 10.1016/j.ahj.2009.09.017, PubMed 19958854

Sikkeland LI, Eduard W, Stangeland AM, Thorgersen EB, Haug T, Aukrust P, Halvorsen B, Mollnes TE, Kongerud J (2009)
Occupational exposure to bacterial single cell protein induces inflammation in lung and blood
Inhal Toxicol, 21 (8), 674-81
DOI 10.1080/08958370802491425, PubMed 19558225

Skogøy K, Laurini R, Aasheim ET (2009)
[Pregnancy shortly after bariatric surgery]
Tidsskr Nor Laegeforen, 129 (6), 534-6
DOI 10.4045/tidsskr.09.34019, PubMed 19291886

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Sandahl Christiansen J, Höybye C (2009)
Assessment of physical function in adults with Prader-Willi syndrome
Disabil Rehabil, 31 (21), 1780-4
DOI 10.1080/09638280902751980, PubMed 19479512

Stepien M, Banach M, Mikhailidis DP, Gluba A, Kjeldsen SE, Rysz J (2009)
Role and significance of statins in the treatment of hypertensive patients
Curr Med Res Opin, 25 (8), 1995-2005
DOI 10.1185/03007990903098081, PubMed 19555312

Strandberg TE, Holme I, Faergeman O, Kastelein JJ, Lindahl C, Larsen ML, Olsson AG, Pedersen TR, Tikkanen MJ, IDEAL Study Group (2009)
Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction
Am J Cardiol, 103 (10), 1381-5
DOI 10.1016/j.amjcard.2009.01.377, PubMed 19427432

Svendsen M, Helgeland M, Tonstad S (2009)
The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome
J Hum Nutr Diet, 22 (1), 55-63
DOI 10.1111/j.1365-277X.2008.00920.x, PubMed 19192027

Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP (2009)
Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study
Scand J Clin Lab Invest, 69 (2), 282-7
DOI 10.1080/00365510802538188, PubMed 18972257

Tikkanen MJ, Holme I, Cater NB, Szarek M, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR, Incremental DEcrease through Aggressive Lipid Lowering Investigators (2009)
Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study)
Am J Cardiol, 103 (5), 577-82
DOI 10.1016/j.amjcard.2008.10.029, PubMed 19231315

Tikkanen MJ, Szarek M, Fayyad R, Holme I, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR, IDEAL Investigators (2009)
Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial
J Am Coll Cardiol, 54 (25), 2353-7
DOI 10.1016/j.jacc.2009.08.035, PubMed 20082922

Tjugen TB, Flaa A, Kjeldsen SE (2009)
High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension
Prog Cardiovasc Dis, 52 (1), 20-5
DOI 10.1016/j.pcad.2009.05.008, PubMed 19615489

Tobin KA, Holven KB, Retterstøl K, Strøm E, Ose L, Aukrust P, Nenseter MS (2009)
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins
Br J Nutr, 102 (12), 1783-9
DOI 10.1017/S0007114509991048, PubMed 19682403

Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE (2009)
Association between serum 25(OH)D and death from prostate cancer
Br J Cancer, 100 (3), 450-4
DOI 10.1038/sj.bjc.6604865, PubMed 19156140

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J (2009)
Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly
J Clin Endocrinol Metab, 95 (1), 361-8
DOI 10.1210/jc.2009-0422, PubMed 19880791

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust PL, Bollerslev J (2009)
Associations between Body Composition, Circulating Interleukin-1 Receptor Antagonist, Osteocalcin, and Insulin Metabolism in Active Acromegaly
Endocr Rev, 30 (7), 927
DOI 10.1210/edrv.30.7.9997, PubMed 28199500

Ueland T, Otterdal K, Lekva T, Halvorsen B, Gabrielsen A, Sandberg WJ, Paulsson-Berne G, Pedersen TM, Folkersen L, Gullestad L, Oie E, Hansson GK, Aukrust P (2009)
Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis
Arterioscler Thromb Vasc Biol, 29 (8), 1228-34
DOI 10.1161/ATVBAHA.109.189761, PubMed 19498175

Ueland T, Wilson SG, Amirul Islam FM, Mullin B, Devine A, Bollerslev J, Zhu K, Prince RL (2009)
A cohort study of the effects of serum osteoprotegerin and osteoprotegerin gene polymorphisms on cardiovascular mortality in elderly women
Clin Endocrinol (Oxf), 71 (6), 828-33
DOI 10.1111/j.1365-2265.2009.03605.x, PubMed 19508593

Vangen S, Jenum AK, Graff-Iversen S, Idland G (2009)
[Is gender perspective on health of the elderly necessary?]
Tidsskr Nor Laegeforen, 129 (6), 538-9
DOI 10.4045/tidsskr.08.0040, PubMed 19282892

Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O (2009)
The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension
J Hypertens, 27 (4), 769-73
DOI 10.1097/HJH.0b013e328326f7eb, PubMed 19293724

Wangensteen T, Kolsgaard ML, Mattingsdal M, Joner G, Tonstad S, Undlien D, Retterstol L (2009)
Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway
Exp Clin Endocrinol Diabetes, 117 (6), 266-73
DOI 10.1055/s-0028-1102942, PubMed 19301229

Wennersberg MH, Smedman A, Turpeinen AM, Retterstøl K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B (2009)
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Am J Clin Nutr, 90 (4), 960-8
DOI 10.3945/ajcn.2009.27664, PubMed 19710195

Yndestad A, Haukeland JW, Dahl TB, Bjøro K, Gladhaug IP, Berge C, Damås JK, Haaland T, Løberg EM, Linnestad P, Birkeland K, Konopski Z, Halvorsen B, Berge RK, Aukrust P (2009)
A complex role of activin A in non-alcoholic fatty liver disease
Am J Gastroenterol, 104 (9), 2196-205
DOI 10.1038/ajg.2009.318, PubMed 19532130

Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, Espevik T, Frøland SS, Husberg C, Christensen G, Dickstein K, Kjekshus J, Øie E, Gullestad L, Aukrust P (2009)
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
Eur Heart J, 30 (10), 1229-36
DOI 10.1093/eurheartj/ehp088, PubMed 19329498

Yndestad A, Larsen KO, Oie E, Ueland T, Smith C, Halvorsen B, Sjaastad I, Skjønsberg OH, Pedersen TM, Anfinsen OG, Damås JK, Christensen G, Aukrust P, Andreassen AK (2009)
Elevated levels of activin A in clinical and experimental pulmonary hypertension
J Appl Physiol (1985), 106 (4), 1356-64
DOI 10.1152/japplphysiol.90719.2008, PubMed 19196915

Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM (2009)
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension
J Hypertens, 27 (4), 673-9
DOI 10.1097/HJH.0b013e3283298ea2, PubMed 19516168

Zidek W, Naditch-Brûlé L, Perlini S, Farsang C, Kjeldsen SE (2009)
Blood pressure control and components of the metabolic syndrome: the GOOD survey
Cardiovasc Diabetol, 8, 51
DOI 10.1186/1475-2840-8-51, PubMed 19754934

Publications Division of Medicine

Publications (original articles or review articles) published in 2009 from OUS - Department of Endocrinology, Morbid Obesity and Preventive Medicine

117 publications found

Aas AM, Ohrvik J, Malmberg K, Rydén L, Birkeland KI, DIGAMI 2 Investigators (2009)
Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study
Diabetes Obes Metab, 11 (4), 323-9
DOI 10.1111/j.1463-1326.2008.00964.x, PubMed 19267710

Aasen G, Fagertun H, Tonstad S, Halse J (2009)
Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men
Scand J Clin Lab Invest, 69 (2), 181-9
DOI 10.1080/00365510802464641, PubMed 18937100

Aasheim ET, Björkman S, Søvik TT, Engström M, Hanvold SE, Mala T, Olbers T, Bøhmer T (2009)
Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch
Am J Clin Nutr, 90 (1), 15-22
DOI 10.3945/ajcn.2009.27583, PubMed 19439456

Aasheim ET, Frigstad SO, Søvik TT, Birkeland KI, Haukeland JW (2009)
Hyperinsulinemic hypoglycemia and liver cirrhosis presenting after duodenal switch: a case report
Surg Obes Relat Dis, 6 (4), 441-3
DOI 10.1016/j.soard.2009.11.007, PubMed 20096646

Abedini S, Holme I, Fellström B, Jardine A, Cole E, Maes B, Holdaas H, ALERT Study Group (2009)
Cerebrovascular events in renal transplant recipients
Transplantation, 87 (1), 112-7
DOI 10.1097/TP.0b013e31818bfce8, PubMed 19136900

Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A, Cole E, Maes B, Neumayer HH, Grønhagen-Riska C, Ambühl P, Holdaas H, ALERT study group (2009)
Inflammation in renal transplantation
Clin J Am Soc Nephrol, 4 (7), 1246-54
DOI 10.2215/CJN.00930209, PubMed 19541816

Aksnes TA, Kjeldsen SE, Schmieder RE (2009)
Hypertension and atrial fi brillation with emphasis on prevention
Blood Press, 18 (3), 94-8
DOI 10.1080/08037050903040744, PubMed 20499443

Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D (2009)
Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study
Hypertension, 55 (2), 333-8
DOI 10.1161/HYPERTENSIONAHA.109.143982, PubMed 20038753

Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J (2009)
Time for new indications for statins?
Med Sci Monit, 15 (12), MS1-5
PubMed 19946240

Bangstad HJ, Seljeflot I, Berg TJ, Hanssen KF (2009)
Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes
Scand J Clin Lab Invest, 69 (1), 138-44
DOI 10.1080/00365510802444080, PubMed 18846477

Birkenaes AB, Birkeland KI, Friis S, Opjordsmoen S, Andreassen OA (2009)
Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions
J Clin Psychopharmacol, 29 (2), 109-16
DOI 10.1097/JCP.0b013e31819b95fc, PubMed 19512971

Bollerslev J, Fougner SL, Berg JP (2009)
New directions in pharmacological treatment of acromegaly
Expert Opin Investig Drugs, 18 (1), 13-22
DOI 10.1517/13543780802554357, PubMed 19053878

Bollerslev J, Rosen T, Mollerup CL, Nordenström J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S, SIPH Study Group (2009)
Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism
J Clin Endocrinol Metab, 94 (7), 2255-61
DOI 10.1210/jc.2008-2742, PubMed 19351725

Borota OC, Scheithauer BW, Fougner SL, Hald JK, Ramm-Pettersen J, Bollerslev J (2009)
Spindle cell oncocytoma of the adenohypophysis: report of a case with marked cellular atypia and recurrence despite adjuvant treatment
Clin Neuropathol, 28 (2), 91-5
DOI 10.5414/npp28091, PubMed 19353839

Brun H, Holmstrøm H, Thaulow E, Damås JK, Yndestad A, Aukrust P, Ueland T (2009)
Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation
Congenit Heart Dis, 4 (3), 153-9
DOI 10.1111/j.1747-0803.2009.00297.x, PubMed 19489942

Carvalho CM, Oliveira JE, Almeida BE, Ueda EK, Torjesen PA, Bartolini P, Ribela MT (2009)
Efficient isolation of the subunits of recombinant and pituitary glycoprotein hormones
J Chromatogr A, 1216 (9), 1431-8
DOI 10.1016/j.chroma.2008.12.096, PubMed 19167716

Dahl CP, Husberg C, Gullestad L, Waehre A, Damås JK, Vinge LE, Finsen AV, Ueland T, Florholmen G, Aakhus S, Halvorsen B, Aukrust P, Oie E, Yndestad A, Christensen G (2009)
Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling
Circ Heart Fail, 2 (6), 624-32
DOI 10.1161/CIRCHEARTFAILURE.108.821074, PubMed 19919988

de Simone G, Okin PM, Gerdts E, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Kjeldsen SE, Devereux RB (2009)
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study
Nutr Metab Cardiovasc Dis, 19 (9), 634-40
DOI 10.1016/j.numecd.2008.12.012, PubMed 19361968

De Stefani E, Aune D, Boffetta P, Deneo-Pellegrini H, Ronco AL, Acosta G, Brennan P, Ferro G, Mendilaharsu M (2009)
Salted meat consumption and the risk of cancer: a multisite case-control study in Uruguay
Asian Pac J Cancer Prev, 10 (5), 853-7
PubMed 20104978

De Stefani E, Deneo-Pellegrini H, Boffetta P, Ronco AL, Aune D, Acosta G, Mendilaharsu M, Brennan P, Ferro G (2009)
Dietary patterns and risk of cancer: a factor analysis in Uruguay
Int J Cancer, 124 (6), 1391-7
DOI 10.1002/ijc.24035, PubMed 19058195

Delmas PD, Munoz F, Black DM, Cosman F, Boonen S, Watts NB, Kendler D, Eriksen EF, Mesenbrink PG, Eastell R, HORIZON-PFT Research Group (2009)
Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis
J Bone Miner Res, 24 (9), 1544-51
DOI 10.1359/jbmr.090310, PubMed 19338427

Dolgos S, Hartmann A, Bønsnes S, Isaksen GA, Godang K, Ueland T, Pfeffer P, Bollerslev J (2009)
Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation
Scand J Clin Lab Invest, 69 (2), 161-7
DOI 10.1080/00365510802449634, PubMed 18972258

Dolgos S, Hartmann A, Jenssen T, Isaksen GA, Pfeffer P, Bollerslev J (2009)
Determinants of short-term changes in body composition following renal transplantation
Scand J Urol Nephrol, 43 (1), 76-83
DOI 10.1080/00365590802273226, PubMed 18777442

Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM, HORIZON Pivotal Fracture Trial (2009)
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial
Osteoporos Int, 21 (7), 1277-85
DOI 10.1007/s00198-009-1077-9, PubMed 19802508

Eggum R, Ueland T, Mollnes TE, Videm V, Fiane AE, Aukrust P, Lindberg HL (2009)
Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery
Interact Cardiovasc Thorac Surg, 10 (1), 76-80
DOI 10.1510/icvts.2009.213876, PubMed 19822605

Einvik G, Ekeberg O, Klemsdal TO, Sandvik L, Hjerkinn EM (2009)
Physical distress is associated with cardiovascular events in a high risk population of elderly men
BMC Cardiovasc Disord, 9, 14
DOI 10.1186/1471-2261-9-14, PubMed 19331677

Einvik G, Ekeberg O, Lavik JG, Ellingsen I, Klemsdal TO, Hjerkinn EM (2009)
The influence of long-term awareness of hyperlipidemia and of 3 years of dietary counseling on depression, anxiety, and quality of life
J Psychosom Res, 68 (6), 567-72
DOI 10.1016/j.jpsychores.2009.11.004, PubMed 20488274

Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES (2009)
Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry
J Clin Endocrinol Metab, 94 (12), 4882-90
DOI 10.1210/jc.2009-1368, PubMed 19858318

Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC, Larsen ML, Lindahl C, Olsson AG, Tikkanen MJ, Waters DD, Pedersen TR, Steering Committees of IDEAL and TNT Trials (2009)
Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease
Am J Cardiol, 104 (4), 459-63
DOI 10.1016/j.amjcard.2009.04.008, PubMed 19660594

Fjalestad T, Falch JA, Stromsoe K (2009)
Proximal humeral fractures and relation to osteoporosis: a cohort study of 49 hospitalized patients with 50 fractures
Eur. J. Orthop. Surg. Traumatol., 19 (7), 461-466

Graesdal A (2009)
[Use of omega-3 fatty acids in the prevention of heart disease]
Tidsskr Nor Laegeforen, 129 (20), 2109-12
DOI 10.4045/tidsskr.08.0447, PubMed 19855449

Gudmundsdottir H, Taarnhøj NC, Strand AH, Kjeldsen SE, Høieggen A, Os I (2009)
Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men
J Hum Hypertens, 24 (8), 505-13
DOI 10.1038/jhh.2009.94, PubMed 20010619

Halvorsen B, Heggen E, Ueland T, Smith C, Sandberg WJ, Damås JK, Otterdal K, Tonstad S, Aukrust P (2009)
Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
Eur J Endocrinol, 162 (2), 267-73
DOI 10.1530/EJE-09-0706, PubMed 19926782

Hampson SE, Tonstad S, Irgens LM, Meltzer HM, Vollrath ME (2009)
Mothers' negative affectivity during pregnancy and food choices for their infants
Int J Obes (Lond), 34 (2), 327-31
DOI 10.1038/ijo.2009.230, PubMed 19918247

Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M (2009)
Long-term stability of cardiovascular and catecholamine responses to stress tests: an 18-year follow-up study
Hypertension, 55 (1), 131-6
DOI 10.1161/HYPERTENSIONAHA.109.143164, PubMed 19948985

Haukeland JW, Konopski Z, Eggesbø HB, von Volkmann HL, Raschpichler G, Bjøro K, Haaland T, Løberg EM, Birkeland K (2009)
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
Scand J Gastroenterol, 44 (7), 853-60
DOI 10.1080/00365520902845268, PubMed 19811343

Heggen E, Granlund L, Pedersen JI, Holme I, Ceglarek U, Thiery J, Kirkhus B, Tonstad S (2009)
Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations
Nutr Metab Cardiovasc Dis, 20 (4), 258-65
DOI 10.1016/j.numecd.2009.04.001, PubMed 19748247

Hjelmesaeth J, Hofsø D, Aasheim ET, Jenssen T, Moan J, Hager H, Røislien J, Bollerslev J (2009)
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study
Cardiovasc Diabetol, 8, 7
DOI 10.1186/1475-2840-8-7, PubMed 19187564

Hofsø D, Jenssen T, Bollerslev J, Røislien J, Hager H, Hjelmesaeth J (2009)
Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study
Diabetes Res Clin Pract, 86 (1), e9-11
DOI 10.1016/j.diabres.2009.06.016, PubMed 19608292

Hofsø D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, Aukrust P, Røislien J, Hjelmesaeth J (2009)
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
Eur J Endocrinol, 161 (3), 451-8
DOI 10.1530/EJE-09-0421, PubMed 19542241

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Eur J Heart Fail, 11 (11), 1036-42
DOI 10.1093/eurjhf/hfp129, PubMed 19801574

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
J Intern Med, 266 (6), 558-70
DOI 10.1111/j.1365-2796.2009.02133.x, PubMed 19563390

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ann Med, 41 (7), 522-32
DOI 10.1080/07853890903089453, PubMed 19657769

Holme I, Fayyad R, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Holdaas H, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial
J Intern Med, 267 (6), 567-75
DOI 10.1111/j.1365-2796.2009.02176.x, PubMed 20141566

Holme I, Fellstrom B, Jardine A, Holdaas H (2009)
Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients
Atherosclerosis, 208 (1), 234-9
DOI 10.1016/j.atherosclerosis.2009.06.020, PubMed 19596331

Holme I, Strandberg TE, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)
Atherosclerosis, 205 (2), 522-7
DOI 10.1016/j.atherosclerosis.2009.01.023, PubMed 19327776

Holme I, Szarek M, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study
Eur J Cardiovasc Prev Rehabil, 16 (3), 315-20
DOI 10.1097/HJR.0b013e32832130f5, PubMed 19322096

Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, Agartz I, Ueland T, Andreassen OA (2009)
Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
Bipolar Disord, 11 (7), 726-34
DOI 10.1111/j.1399-5618.2009.00757.x, PubMed 19839997

Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
J Diabetes, 1 (3), 182-7
DOI 10.1111/j.1753-0407.2009.00031.x, PubMed 20923537

Johansen OE, Vanberg PJ, Kilhovd BK, Jørgensen AP (2009)
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
Vasc Health Risk Manag, 5 (1), 121-8
PubMed 19436668

Jorde R, Sneve M, Torjesen P, Figenschau Y (2009)
No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year
J Intern Med, 267 (5), 462-72
DOI 10.1111/j.1365-2796.2009.02181.x, PubMed 20141565

Khoury J, Amundsen AL, Tonstad S, Henriksen T, Ose L, Retterstøl K, Iversen PO (2009)
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
Acta Obstet Gynecol Scand, 88 (2), 222-6
DOI 10.1080/00016340802503047, PubMed 18972234

Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Hanssen KF, Laakso M (2009)
Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women
Atherosclerosis, 205 (2), 590-4
DOI 10.1016/j.atherosclerosis.2008.12.041, PubMed 19185865

Kjeldsen SE, Devereux RB, Hille DA, Lyle PA, Dahlöf B, Julius S, Edelman JM, Snapinn SM, de Faire U, Fyhrquist F, Ibsen H, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
Blood Press, 18 (6), 348-61
DOI 10.3109/08037050903460590, PubMed 20001655

Kjensli A, Falch JA, Ryg M, Blenk T, Armbrecht G, Diep LM, Ellingsen I (2009)
High prevalence of vertebral deformities in COPD patients: relationship to disease severity
Eur Respir J, 33 (5), 1018-24
DOI 10.1183/09031936.00073908, PubMed 19129288

Klemsdal TO, Holme I, Nerland H, Pedersen TR, Tonstad S (2009)
Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome
Nutr Metab Cardiovasc Dis, 20 (3), 195-201
DOI 10.1016/j.numecd.2009.03.010, PubMed 19502017

Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven KB, Halvorsen B, Aukrust P, Tonstad S (2009)
Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome
Scand J Clin Lab Invest, 69 (8), 858-64
DOI 10.3109/00365510903348677, PubMed 19929281

Landrø L, Damås JK, Halvorsen B, Fevang B, Ueland T, Otterdal K, Heggelund L, Frøland SS, Aukrust P (2009)
CXCL16 in HIV infection - a link between inflammation and viral replication
Eur J Clin Invest, 39 (11), 1017-24
DOI 10.1111/j.1365-2362.2009.02207.x, PubMed 19674076

Lekva T, Bollerslev J, Kristo C, Olstad OK, Ueland T, Jemtland R (2009)
The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis
J Clin Endocrinol Metab, 95 (1), 246-55
DOI 10.1210/jc.2009-0595, PubMed 19875485

Lekva T, Bollerslev J, Kristo CL, Olstad OK, Ueland T, Jemtland R (2009)
The Glucocorticoid-Induced Leucine Zipper Gene (GILZ) Expression Decreases after Successful Treatment of Patients with Endogenous Cushing's Syndrome and May Play a Role in Glucocorticoid-Induced Osteoporosis
Endocr Rev, 30 (7), 932
DOI 10.1210/edrv.30.7.9985, PubMed 28199557

Liavaag AH, Tonstad S, Pripp AH, Tropé C, Dørum A (2009)
Prevalence and determinants of metabolic syndrome and elevated Framingham risk score in epithelial ovarian cancer survivors: a controlled observational study
Int J Gynecol Cancer, 19 (4), 634-40
DOI 10.1111/IGC.0b013e3181a13058, PubMed 19509562

Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES (2009)
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone
Eur J Endocrinol, 160 (6), 993-1002
DOI 10.1530/EJE-08-0880, PubMed 19282465

Madsen LH, Lund T, Grieg Z, Nygaard S, Holmvang L, Jurlander B, Grande P, Christensen G, Atar D (2009)
Cardiac troponin I degradation in serum of patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous septal ablation
Cardiology, 114 (3), 167-73
DOI 10.1159/000226596, PubMed 19571537

Malterud K, Tonstad S (2009)
Preventing obesity: challenges and pitfalls for health promotion
Patient Educ Couns, 76 (2), 254-9
DOI 10.1016/j.pec.2008.12.012, PubMed 19157764

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Blood Press, 18 (6), 308-47
DOI 10.3109/08037050903450468, PubMed 20001654

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
J Hypertens, 27 (11), 2121-58
DOI 10.1097/HJH.0b013e328333146d, PubMed 19838131

Meuwese MC, de Groot E, Duivenvoorden R, Trip MD, Ose L, Maritz FJ, Basart DC, Kastelein JJ, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA, CAPTIVATE Investigators (2009)
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial
JAMA, 301 (11), 1131-9
DOI 10.1001/jama.301.11.1131, PubMed 19293413

Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Mohanavelu S, Rouleau J, Fox K, Pedersen TR, Califf RM (2009)
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome
Clin J Am Soc Nephrol, 4 (11), 1811-7
DOI 10.2215/CJN.03510509, PubMed 19820133

Morin DP, Oikarinen L, Viitasalo M, Toivonen L, Nieminen MS, Kjeldsen SE, Dahlöf B, John M, Devereux RB, Okin PM (2009)
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study
Eur Heart J, 30 (23), 2908-14
DOI 10.1093/eurheartj/ehp321, PubMed 19687165

Nätt D, Lindqvist N, Stranneheim H, Lundeberg J, Torjesen PA, Jensen P (2009)
Inheritance of acquired behaviour adaptations and brain gene expression in chickens
PLoS One, 4 (7), e6405
DOI 10.1371/journal.pone.0006405, PubMed 19636381

Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group (2009)
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study
Arthritis Rheum, 60 (4), 1060-4
DOI 10.1002/art.24379, PubMed 19333947

Okin PM, Devereux RB, Kjeldsen SE, Edelman JM, Dahlöf B (2009)
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study
J Hypertens, 27 (11), 2271-7
DOI 10.1097/HJH.0b013e328330b66b, PubMed 19834342

Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators (2009)
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)
Circulation, 119 (14), 1883-91
DOI 10.1161/CIRCULATIONAHA.108.812313, PubMed 19332468

Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
J Hypertens, 27 (3), 567-74
DOI 10.1097/HJH.0b013e32831daf96, PubMed 19262226

Orn S, Breland UM, Mollnes TE, Manhenke C, Dickstein K, Aukrust P, Ueland T (2009)
The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction
Am J Cardiol, 104 (9), 1179-83
DOI 10.1016/j.amjcard.2009.06.028, PubMed 19840558

Ørn S, Manhenke C, Ueland T, Damås JK, Mollnes TE, Edvardsen T, Aukrust P, Dickstein K (2009)
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
Eur Heart J, 30 (10), 1180-6
DOI 10.1093/eurheartj/ehp070, PubMed 19299430

Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD (2009)
Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
Brain Behav Immun, 23 (6), 868-74
DOI 10.1016/j.bbi.2009.04.003, PubMed 19362138

Ose L, Budinski D, Hounslow N, Arneson V (2009)
Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia
Curr Med Res Opin, 25 (11), 2755-64
DOI 10.1185/03007990903290886, PubMed 19785568

Ose L, Budinski D, Hounslow N, Arneson V (2009)
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia
Atherosclerosis, 210 (1), 202-8
DOI 10.1016/j.atherosclerosis.2009.12.009, PubMed 20080236

Osmancevic A, Nilsen LT, Landin-Wilhelmsen K, Søyland E, Abusdal Torjesen P, Hagve TA, Nenseter MS, Krogstad AL (2009)
Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis
J Eur Acad Dermatol Venereol, 23 (10), 1133-40
DOI 10.1111/j.1468-3083.2009.03245.x, PubMed 19453805

Parhofer KG, Birkeland KI, DeFronzo R, Del Prato S, Bhaumik A, Ptaszynska A (2009)
Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)
Int J Clin Pract, 64 (2), 160-8
DOI 10.1111/j.1742-1241.2009.02246.x, PubMed 19929980

Pedersen TR (2009)
Lipid-lowering drugs and risk for cancer
Curr Atheroscler Rep, 11 (5), 350-7
DOI 10.1007/s11883-009-0053-3, PubMed 19664378

Qvigstad E, Voldner N, Bollerslev J, Henriksen T (2009)
[Diabetes in pregnancy--prevention over generations]
Tidsskr Nor Laegeforen, 129 (23), 2494-6
DOI 10.4045/tidsskr.09.0712, PubMed 19997141

Qvigstad E, Voldner N, Godang K, Henriksen T, Bollerslev J (2009)
Overweight is associated with impaired beta-cell function during pregnancy: a longitudinal study of 553 normal pregnancies
Eur J Endocrinol, 162 (1), 67-73
DOI 10.1530/EJE-09-0416, PubMed 19841044

Rasmussen T, Stene LC, Samuelsen SO, Cinek O, Wetlesen T, Torjesen PA, Rønningen KS (2009)
Maternal BMI before pregnancy, maternal weight gain during pregnancy, and risk of persistent positivity for multiple diabetes-associated autoantibodies in children with the high-risk HLA genotype: the MIDIA study
Diabetes Care, 32 (10), 1904-6
DOI 10.2337/dc09-0663, PubMed 19592628

Reppe S, Refvem H, Gautvik VT, Olstad OK, Høvring PI, Reinholt FP, Holden M, Frigessi A, Jemtland R, Gautvik KM (2009)
Eight genes are highly associated with BMD variation in postmenopausal Caucasian women
Bone, 46 (3), 604-12
DOI 10.1016/j.bone.2009.11.007, PubMed 19922823

Retterstøl K, Hennig CB, Iversen PO (2009)
Improved plasma lipids and body weight in overweight/obese patients with type III hyperlipoproteinemia after 4 weeks on a low glycemic diet
Clin Nutr, 28 (2), 213-5
DOI 10.1016/j.clnu.2009.01.018, PubMed 19232793

Rødland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Frøland SS (2009)
Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis
Infect Immun, 78 (3), 1269-75
DOI 10.1128/IAI.01091-09, PubMed 20008537

Rønning P, Andresen PA, Hald JK, Heimdal K, Scheie D, Schreiner T, Helseth E (2009)
Low frequency of VHL germline mutations in Norwegian patients presenting with isolated central nervous system hemangioblastomas--a population-based study
Acta Neurol Scand, 122 (2), 124-31
DOI 10.1111/j.1600-0404.2009.01274.x, PubMed 19814753

Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B, PROactive investigators (2009)
Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)
Diabet Med, 26 (10), 1033-9
DOI 10.1111/j.1464-5491.2009.02816.x, PubMed 19900236

Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B, PROactive investigators (2009)
Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18)
Diabet Med, 26 (12), 1242-9
DOI 10.1111/j.1464-5491.2009.02857.x, PubMed 20002476

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J, dal-OUTCOMES Committees and Investigators (2009)
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
Am Heart J, 158 (6), 896-901.e3
DOI 10.1016/j.ahj.2009.09.017, PubMed 19958854

Sikkeland LI, Eduard W, Stangeland AM, Thorgersen EB, Haug T, Aukrust P, Halvorsen B, Mollnes TE, Kongerud J (2009)
Occupational exposure to bacterial single cell protein induces inflammation in lung and blood
Inhal Toxicol, 21 (8), 674-81
DOI 10.1080/08958370802491425, PubMed 19558225

Skogøy K, Laurini R, Aasheim ET (2009)
[Pregnancy shortly after bariatric surgery]
Tidsskr Nor Laegeforen, 129 (6), 534-6
DOI 10.4045/tidsskr.09.34019, PubMed 19291886

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Sandahl Christiansen J, Höybye C (2009)
Assessment of physical function in adults with Prader-Willi syndrome
Disabil Rehabil, 31 (21), 1780-4
DOI 10.1080/09638280902751980, PubMed 19479512

Stepien M, Banach M, Mikhailidis DP, Gluba A, Kjeldsen SE, Rysz J (2009)
Role and significance of statins in the treatment of hypertensive patients
Curr Med Res Opin, 25 (8), 1995-2005
DOI 10.1185/03007990903098081, PubMed 19555312

Strandberg TE, Holme I, Faergeman O, Kastelein JJ, Lindahl C, Larsen ML, Olsson AG, Pedersen TR, Tikkanen MJ, IDEAL Study Group (2009)
Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction
Am J Cardiol, 103 (10), 1381-5
DOI 10.1016/j.amjcard.2009.01.377, PubMed 19427432

Svendsen M, Helgeland M, Tonstad S (2009)
The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome
J Hum Nutr Diet, 22 (1), 55-63
DOI 10.1111/j.1365-277X.2008.00920.x, PubMed 19192027

Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP (2009)
Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study
Scand J Clin Lab Invest, 69 (2), 282-7
DOI 10.1080/00365510802538188, PubMed 18972257

Tikkanen MJ, Holme I, Cater NB, Szarek M, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR, Incremental DEcrease through Aggressive Lipid Lowering Investigators (2009)
Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study)
Am J Cardiol, 103 (5), 577-82
DOI 10.1016/j.amjcard.2008.10.029, PubMed 19231315

Tikkanen MJ, Szarek M, Fayyad R, Holme I, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR, IDEAL Investigators (2009)
Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial
J Am Coll Cardiol, 54 (25), 2353-7
DOI 10.1016/j.jacc.2009.08.035, PubMed 20082922

Tjugen TB, Flaa A, Kjeldsen SE (2009)
High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension
Prog Cardiovasc Dis, 52 (1), 20-5
DOI 10.1016/j.pcad.2009.05.008, PubMed 19615489

Tobin KA, Holven KB, Retterstøl K, Strøm E, Ose L, Aukrust P, Nenseter MS (2009)
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins
Br J Nutr, 102 (12), 1783-9
DOI 10.1017/S0007114509991048, PubMed 19682403

Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE (2009)
Association between serum 25(OH)D and death from prostate cancer
Br J Cancer, 100 (3), 450-4
DOI 10.1038/sj.bjc.6604865, PubMed 19156140

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J (2009)
Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly
J Clin Endocrinol Metab, 95 (1), 361-8
DOI 10.1210/jc.2009-0422, PubMed 19880791

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust PL, Bollerslev J (2009)
Associations between Body Composition, Circulating Interleukin-1 Receptor Antagonist, Osteocalcin, and Insulin Metabolism in Active Acromegaly
Endocr Rev, 30 (7), 927
DOI 10.1210/edrv.30.7.9997, PubMed 28199500

Ueland T, Otterdal K, Lekva T, Halvorsen B, Gabrielsen A, Sandberg WJ, Paulsson-Berne G, Pedersen TM, Folkersen L, Gullestad L, Oie E, Hansson GK, Aukrust P (2009)
Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis
Arterioscler Thromb Vasc Biol, 29 (8), 1228-34
DOI 10.1161/ATVBAHA.109.189761, PubMed 19498175

Ueland T, Wilson SG, Amirul Islam FM, Mullin B, Devine A, Bollerslev J, Zhu K, Prince RL (2009)
A cohort study of the effects of serum osteoprotegerin and osteoprotegerin gene polymorphisms on cardiovascular mortality in elderly women
Clin Endocrinol (Oxf), 71 (6), 828-33
DOI 10.1111/j.1365-2265.2009.03605.x, PubMed 19508593

Vangen S, Jenum AK, Graff-Iversen S, Idland G (2009)
[Is gender perspective on health of the elderly necessary?]
Tidsskr Nor Laegeforen, 129 (6), 538-9
DOI 10.4045/tidsskr.08.0040, PubMed 19282892

Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O (2009)
The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension
J Hypertens, 27 (4), 769-73
DOI 10.1097/HJH.0b013e328326f7eb, PubMed 19293724

Wangensteen T, Kolsgaard ML, Mattingsdal M, Joner G, Tonstad S, Undlien D, Retterstol L (2009)
Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway
Exp Clin Endocrinol Diabetes, 117 (6), 266-73
DOI 10.1055/s-0028-1102942, PubMed 19301229

Wennersberg MH, Smedman A, Turpeinen AM, Retterstøl K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B (2009)
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Am J Clin Nutr, 90 (4), 960-8
DOI 10.3945/ajcn.2009.27664, PubMed 19710195

Yndestad A, Haukeland JW, Dahl TB, Bjøro K, Gladhaug IP, Berge C, Damås JK, Haaland T, Løberg EM, Linnestad P, Birkeland K, Konopski Z, Halvorsen B, Berge RK, Aukrust P (2009)
A complex role of activin A in non-alcoholic fatty liver disease
Am J Gastroenterol, 104 (9), 2196-205
DOI 10.1038/ajg.2009.318, PubMed 19532130

Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, Espevik T, Frøland SS, Husberg C, Christensen G, Dickstein K, Kjekshus J, Øie E, Gullestad L, Aukrust P (2009)
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
Eur Heart J, 30 (10), 1229-36
DOI 10.1093/eurheartj/ehp088, PubMed 19329498

Yndestad A, Larsen KO, Oie E, Ueland T, Smith C, Halvorsen B, Sjaastad I, Skjønsberg OH, Pedersen TM, Anfinsen OG, Damås JK, Christensen G, Aukrust P, Andreassen AK (2009)
Elevated levels of activin A in clinical and experimental pulmonary hypertension
J Appl Physiol (1985), 106 (4), 1356-64
DOI 10.1152/japplphysiol.90719.2008, PubMed 19196915

Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM (2009)
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension
J Hypertens, 27 (4), 673-9
DOI 10.1097/HJH.0b013e3283298ea2, PubMed 19516168

Zidek W, Naditch-Brûlé L, Perlini S, Farsang C, Kjeldsen SE (2009)
Blood pressure control and components of the metabolic syndrome: the GOOD survey
Cardiovasc Diabetol, 8, 51
DOI 10.1186/1475-2840-8-51, PubMed 19754934